Regeneron’s clinical trials are at the core of this mission. Regeneron is grateful to all clinical trial participants — ...

Dr. Peterson, an experienced clinical researcher with a background in both academic and industry roles, joins from Axogen, where he specialized in therapies for peripheral nerve repair. With expertise ...

Top-line Data for RETHINK-ALZ 52-week Phase 3 trial Expected Before the End of 2024$149.0 Million in Cash and Cash Equivalents at September 30, ...

Senators push a bill to increase federal research on menopause, coordinate the federal government’s existing programs ...

IND cleared by FDA and dosing in the Phase 1 clinical trial initiated, with data expected in the first half of 2025Sanofi ...

This research challenges the traditional view of cellular metabolism as merely a background cellular function, positioning it instead as an active director of embryonic development. More ...

A new high-resolution neural recording method developed by Johns Hopkins APL and the School of Medicine detects neural ...

Cytophone clinical prototype The ... an invasive blood sample. Now, a research collaboration from USA and Cameroon has ...

Oculis has multiple late-stage programs and catalysts. Click here to find out why I think OCS stock looks attractive.

San Francisco–based Ossium Health has carried out three transplants for cancer patients using stem cells from deceased donors ...

Bristol-Myers Squibb Company ( NYSE: BMY) Guggenheim Securities Inaugural Healthcare Innovation Conference November 11, 2024 10:00 AM ET Samit Hirawat - EVP, Chief Medical Officer, Global Drug ...